Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo
Open Access
- 25 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (11), 1545-1549
- https://doi.org/10.1161/01.cir.0000055323.57885.88
Abstract
Background— It has been found recently that the MRI contrast agent superparamagnetic iron oxide (SPIO) localizes to aortic atherosclerotic plaques. We therefore asked whether SPIO might be used to monitor monocyte recruitment into aortic atherosclerotic plaques.Keywords
This publication has 7 references indexed in Scilit:
- Superparamagnetic Iron Oxide–Enhanced MRI of Atherosclerotic Plaques in Watanabe Hereditable Hyperlipidemic RabbitsInvestigative Radiology, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Activated inflammatory cells are associated with plaque rupture in carotid artery stenosisSurgery, 1997
- A new approach to determining the rates of recruitment of circulating leukocytes into tissues: Application to the measurement of leukocyte recruitment into atherosclerotic lesionsProceedings of the National Academy of Sciences, 1997
- Antithrombotic Effect of Ticlopidine on Occlusive Thrombi of Small Coronary Arteries in (NZWxBXSB)F1 Male Mice with Myocardial Infarction and Systemic Lupus ErythematosusJournal of Cardiovascular Pharmacology, 1995
- Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolismMagnetic Resonance Imaging, 1991
- Visualization of monocyte recruitment into atherosclerotic arteries using fluorescent labellingAtherosclerosis, 1988